Vascular and Renal Translational Research Group, Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRBLleida), 25196 Lleida, Spain.
Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova-Santa Maria, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.
Nutrients. 2024 Feb 28;16(5):691. doi: 10.3390/nu16050691.
Obesity is one of the main causes of chronic kidney disease; however, the precise molecular mechanisms leading to the onset of kidney injury and dysfunction in obesity-associated nephropathy remain unclear. The present study aimed to unveil the kidney microRNA (miRNA) expression profile in a model of obesity-induced kidney disease in C57BL/6J mice using next-generation sequencing (NGS) analysis. High-fat diet (HFD)-induced obesity led to notable structural alterations in tubular and glomerular regions of the kidney, increased renal expression of proinflammatory and profibrotic genes, as well as an elevated renal expression of genes involved in cellular lipid metabolism. The miRNA sequencing analysis identified a set of nine miRNAs differentially expressed in the kidney upon HFD feeding, with miR-5099, miR-551b-3p, miR-223-3p, miR-146a-3p and miR-21a-3p showing the most significant differential expression between standard diet (STD) and HFD mice. A validation analysis showed that the expression levels of miR-5099, miR-551b-3p and miR-146a-3p were consistent with NGS results, while Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses revealed that these three validated miRNAs modulated target genes involved in metabolic and adipocytokine pathways, fatty acid and lipid metabolism, and inflammatory, senescence and profibrotic pathways. Our results suggest that differentially expressed miRNAs play pivotal roles in the intricate pathophysiology of obesity-associated kidney disease and could potentially create novel treatment strategies to counteract the deleterious effects of obesity on kidney function.
肥胖是慢性肾脏病的主要原因之一;然而,导致肥胖相关肾病中肾脏损伤和功能障碍的精确分子机制仍不清楚。本研究旨在使用下一代测序(NGS)分析揭示肥胖诱导的 C57BL/6J 小鼠肾病模型中的肾脏 microRNA(miRNA)表达谱。高脂肪饮食(HFD)诱导的肥胖导致肾脏管状和肾小球区域的显著结构改变,促炎和促纤维化基因在肾脏中的表达增加,以及涉及细胞脂质代谢的基因在肾脏中的表达升高。miRNA 测序分析鉴定出一组在 HFD 喂养后肾脏中差异表达的 9 个 miRNA,miR-5099、miR-551b-3p、miR-223-3p、miR-146a-3p 和 miR-21a-3p 在标准饮食(STD)和 HFD 小鼠之间表现出最显著的差异表达。验证分析表明,miR-5099、miR-551b-3p 和 miR-146a-3p 的表达水平与 NGS 结果一致,而京都基因与基因组百科全书(KEGG)和基因本体论(GO)富集分析表明,这三个验证的 miRNA 调节了参与代谢和脂肪细胞因子途径、脂肪酸和脂质代谢以及炎症、衰老和促纤维化途径的靶基因。我们的研究结果表明,差异表达的 miRNA 在肥胖相关肾病的复杂病理生理学中发挥着关键作用,并可能为对抗肥胖对肾功能的有害影响创造新的治疗策略。